March 11, 2021 Environ, Ag./Food & Bev Licensing, IP, and Legal

Illumina and Harvard Pilgrim Health Care Real-World Evidence Study Demonstrates Cost-Effectiveness of Offering NIPT to All Pregnant Women

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN), along with researchers at the University of Colorado and Harvard Pilgrim Health Care (HPHC), reported study results evaluating the impact of an innovative risk-sharing agreement that opened insurance coverage of non-invasive prenatal testing (NIPT) for pregnant women under the age of 35. Through this partnership, thousands of women gained... Read more

March 11, 2021 Clinical Research/Diagn. Microscopy PR/Corporate

Roche’s awarded WHO prequalification for the HIV and HCV diagnostic tests on the cobas 6800/8800 Systems

For patients living in areas with limited healthcare resources, WHO prequalification ensures access to the highest quality diagnostics Access to broader reliable diagnostic solutions helps healthcare communities working to expedite and increase disease elimination programs Roche’s Global Access Program provides innovative diagnostic solutions improving disease and patient management for those most in need Basel, 11... Read more

March 11, 2021 Bio/Pharma/CRO Microscopy

Roche provides update on the phase III REMDACTA trial of Actemra/RoActemra plus Veklury in patients with severe COVID-19 pneumonia

The REMDACTA clinical trial of Actemra/RoActemra plus Veklury did not meet its primary endpoint of improved time to hospital discharge for patients with severe COVID-19 pneumonia or its key secondary endpoints compared to Veklury alone Roche will submit the REMDACTA results to a peer-reviewed journal Basel, 11 March 2021 – Roche (SIX: RO, ROG; OTCQX:... Read more

March 10, 2021 Life Science Tools Product Launch

PCR Biosystems launches advanced Bst Polymerase reagents for accelerated DNA and RNA amplification

Mar 10, 2021 PCR Biosystems, the UK-based specialists in DNA and RNA analysis, have launched a range of IsoFast™ Bst Polymerase reagents for rapid, robust and sensitive DNA and RNA amplification. Through its nucleic acid strand displacement capabilities, Bst polymerase eliminates the need for the high temperature denaturation step associated with traditional Taq enzymes. This enables faster... Read more

March 10, 2021 Lab Top-10 PR/Corporate

Thermo Fisher Scientific Investments Support Rapidly Increasing Bioprocessing Production

Thermo Fisher Scientific Investments Support Rapidly Increasing Bioprocessing Production More than $600 million in investments will enable reliable supply of critical materials used to produce new vaccines and biologics WALTHAM, Mass., March 10, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced more than $600 million in capital... Read more

March 10, 2021 Lab Top-10 Product Launch

Thermo Fisher Scientific Launches Customizable TaqMan SARS-CoV-2 Mutation Panel

Panel designed to provide surveillance of ongoing mutations of virus that causes COVID-19 CARLSBAD, Calif., March 10, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced the launch of its Applied Biosystems TaqMan SARS-CoV-2 Mutation Panel, a customizable menu of 22 verified real-time PCR assays for identification of SARS-CoV-2 mutations.... Read more

March 10, 2021 Acad, Gov/Utilities Liq. Handling & Robotics

Luminex Submits Joint SARS-CoV-2 and Flu/RSV Respiratory Panel to FDA for Emergency Use Authorization

Luminex® Corporation (NASDAQ: LMNX) develops, manufactures, and markets proprietary biological testing technologies, with applications throughout the life-sciences industry. Luminex Submits Joint SARS-CoV-2 and Flu/RSV Respiratory Panel to FDA for Emergency Use Authorization Mar 10, 2021 6:30 AM EST AUSTIN, Texas, March 10, 2021 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that it has submitted an... Read more

March 9, 2021 Chromatography Life Science Tools Mass Spectrometry PR/Corporate

Dr. Katharine Knobil Named Agilent’s First Chief Medical Officer

SANTA CLARA, Calif., March 09, 2021  Agilent Technologies Inc. (NYSE: A), today announced that Dr. Katharine (Kate) Knobil is joining Agilent as the company’s chief medical officer (CMO). The chief medical officer at Agilent is a newly created position designed to advise, lead, and elevate the company’s presence in the health-care industry. As Agilent’s first... Read more

March 9, 2021 Clinical Research/Diagn. Licensing, IP, and Legal

Agilent Completes CE-IVD Registration of qRT-PCR In Vitro Diagnostic Kit for SARS-CoV-2 RNA Detection

Kit expands Agilent’s product portfolio aimed at COVID-19 detection SANTA CLARA, Calif., March 09, 2021  Agilent Technologies Inc. (NYSE: A) today announced the launch of a real-time reverse transcription (qRT) PCR-based diagnostic kit for the detection of SARS-CoV-2 RNA. The CE-IVD mark is in accordance with the European Union In Vitro Diagnostic Directive 98/79/EC and... Read more

March 9, 2021 Life Science Tools PR/Corporate Uncategorized

10x Genomics Expands Pleasanton Headquarters with New Facilities at Two Locations

City to Change Street Name to ‘Genomics Place’ PLEASANTON, Calif., March 09, 2021 (GLOBE NEWSWIRE) — 10x Genomics, Inc. (Nasdaq: TXG) today announced expansion plans to support the company’s continued growth in Pleasanton across two properties. Along with the leasing of a second building in the same complex as its current headquarters, 10x has acquired the... Read more